Southern Tunisia: A still high endemicity area for hepatitis A.

Hepatitis A (HAV) and E (HEV) viruses are responsible for enterically transmitted hepatitis. Tunisia is reported to be of intermediate endemicity for HAV and of low seroprevalence for HEV; however, data from rural areas of South Tunisia are lacking.Sera from 216 asymptomatic pregnant women and from...

Full description

Bibliographic Details
Main Authors: Houcine Neffatti, Patricia Lebraud, Corinne Hottelet, Jawher Gharbi, Taieb Challouf, Anne-Marie Roque-Afonso
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5398567?pdf=render
id doaj-7699fa6b7a714dbcba336b9cf27ed429
record_format Article
spelling doaj-7699fa6b7a714dbcba336b9cf27ed4292020-11-24T22:03:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01124e017588710.1371/journal.pone.0175887Southern Tunisia: A still high endemicity area for hepatitis A.Houcine NeffattiPatricia LebraudCorinne HotteletJawher GharbiTaieb ChalloufAnne-Marie Roque-AfonsoHepatitis A (HAV) and E (HEV) viruses are responsible for enterically transmitted hepatitis. Tunisia is reported to be of intermediate endemicity for HAV and of low seroprevalence for HEV; however, data from rural areas of South Tunisia are lacking.Sera from 216 asymptomatic pregnant women and from 92 patients with acute hepatitis were collected between October 2014 and November 2015. Total and IgM anti-HAV immunoglobulins and anti-HEV IgG and IgM were investigated. Anti-HAV IgM-positive samples were subjected to RT-PCR targeting the VP1/2A region and sequenced. HEV IgM positive samples and all samples from acute hepatitis patients were assessed for HEV RNA.Among pregnant women (mean age 32+/-8), HAV seroprevalence was 98.6%, none presented anti-HAV IgM; HEV seroprevalence was 5.1% and three presented weakly reactive anti-HEV IgM without detectable RNA. Among acute hepatitis patients (mean age 18.5 +/- 14), HEV seroprevalence was 19,5%, none presented anti-HEV IgM, nor HEV RNA. HAV seroprevalence exceeded 90% by age 5 and acute HAV infection was detected in 20 patients (21,7%), younger than patients with other hepatitis causes (9,8 years vs. 20,4 years, p = 0,004); 65% were male. Most acute HAV infections were observed in a coastal area where HAV infections represented 52% of hepatitis etiology. Phylogenetic analysis identified genotype IA strains, clustering close to previously published Tunisian sequences.The present study confirmed a low HEV endemicity and evidenced a still high level of HAV circulation in Southern Tunisia, suggesting distinct dissemination patterns for these viruses.http://europepmc.org/articles/PMC5398567?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Houcine Neffatti
Patricia Lebraud
Corinne Hottelet
Jawher Gharbi
Taieb Challouf
Anne-Marie Roque-Afonso
spellingShingle Houcine Neffatti
Patricia Lebraud
Corinne Hottelet
Jawher Gharbi
Taieb Challouf
Anne-Marie Roque-Afonso
Southern Tunisia: A still high endemicity area for hepatitis A.
PLoS ONE
author_facet Houcine Neffatti
Patricia Lebraud
Corinne Hottelet
Jawher Gharbi
Taieb Challouf
Anne-Marie Roque-Afonso
author_sort Houcine Neffatti
title Southern Tunisia: A still high endemicity area for hepatitis A.
title_short Southern Tunisia: A still high endemicity area for hepatitis A.
title_full Southern Tunisia: A still high endemicity area for hepatitis A.
title_fullStr Southern Tunisia: A still high endemicity area for hepatitis A.
title_full_unstemmed Southern Tunisia: A still high endemicity area for hepatitis A.
title_sort southern tunisia: a still high endemicity area for hepatitis a.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description Hepatitis A (HAV) and E (HEV) viruses are responsible for enterically transmitted hepatitis. Tunisia is reported to be of intermediate endemicity for HAV and of low seroprevalence for HEV; however, data from rural areas of South Tunisia are lacking.Sera from 216 asymptomatic pregnant women and from 92 patients with acute hepatitis were collected between October 2014 and November 2015. Total and IgM anti-HAV immunoglobulins and anti-HEV IgG and IgM were investigated. Anti-HAV IgM-positive samples were subjected to RT-PCR targeting the VP1/2A region and sequenced. HEV IgM positive samples and all samples from acute hepatitis patients were assessed for HEV RNA.Among pregnant women (mean age 32+/-8), HAV seroprevalence was 98.6%, none presented anti-HAV IgM; HEV seroprevalence was 5.1% and three presented weakly reactive anti-HEV IgM without detectable RNA. Among acute hepatitis patients (mean age 18.5 +/- 14), HEV seroprevalence was 19,5%, none presented anti-HEV IgM, nor HEV RNA. HAV seroprevalence exceeded 90% by age 5 and acute HAV infection was detected in 20 patients (21,7%), younger than patients with other hepatitis causes (9,8 years vs. 20,4 years, p = 0,004); 65% were male. Most acute HAV infections were observed in a coastal area where HAV infections represented 52% of hepatitis etiology. Phylogenetic analysis identified genotype IA strains, clustering close to previously published Tunisian sequences.The present study confirmed a low HEV endemicity and evidenced a still high level of HAV circulation in Southern Tunisia, suggesting distinct dissemination patterns for these viruses.
url http://europepmc.org/articles/PMC5398567?pdf=render
work_keys_str_mv AT houcineneffatti southerntunisiaastillhighendemicityareaforhepatitisa
AT patricialebraud southerntunisiaastillhighendemicityareaforhepatitisa
AT corinnehottelet southerntunisiaastillhighendemicityareaforhepatitisa
AT jawhergharbi southerntunisiaastillhighendemicityareaforhepatitisa
AT taiebchallouf southerntunisiaastillhighendemicityareaforhepatitisa
AT annemarieroqueafonso southerntunisiaastillhighendemicityareaforhepatitisa
_version_ 1725832004091510784